Immunological aspects of acute viral hepatitis treated with corticosteroids
Singeisen, M.; Stalder, G.A.; Bianchi, L.; Gudat, F.; Schmid, M.
Schweizerische Medizinische Wochenschrift 107(48): 1762-1764
1977
ISSN/ISBN: 0036-7672 PMID: 929138 Document Number: 118648
Acute viral B-hepatitis is the consequence of an effective specific immune response against the hepatitis B-virus with elimination of the virus. Corticosteroids decrease this immune reaction and thereby inhibit virus elimination. In principle, therefore, corticosteroid therapy promotes a transition to chronicity. This theoretical concept is documented practically by 8 patients treated with steroids in the early phase of acute viral hepatitis. Transition to some form of chronic liver disease is documented by serial liver biopsies in all 8 patients. The immunohistological findings showed the presence of HBsAg and HBcAg, as theoretically expected. These 8 selected cases, although uncontrolled, together with the theoretical concept of B-virus elimination, provide evidence against the use of corticosteroids in acute B-hepatitis.